Powder: -20°C for 3 years
In solvent: -80°C for 2 years
CGP 20712 A (CGP 20712 mesylate) is a highly selective antagonist of β1-adrenoceptor (IC50: 0.7 nM). It shows ~10,000-fold selectivity over β2-adrenoceptors.
Description | CGP 20712 A (CGP 20712 mesylate) is a highly selective antagonist of β1-adrenoceptor (IC50: 0.7 nM). It shows ~10,000-fold selectivity over β2-adrenoceptors. |
Targets&IC50 | β1-adrenoceptor:0.7 nM |
In vitro | In myocytes, the activation of adenylate cyclase causes by β2-adrenoceptors is not detected in the presence of 10 nM, 100 nM, or 1000 nM CGP 20712 A [2]. |
In vivo | In 8-day-old rats, pretreatment with 5 mg/kg CGP 20712 A does not change the plasma ACTH response to insulin injection [3]. |
Synonyms | CGP 20712 mesylate |
Molecular Weight | 590.57 |
Formula | C24H29F3N4O8S |
CAS No. | 105737-62-0 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 100 mg/mL (169.33 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP 20712 A 105737-62-0 GPCR/G Protein Neuroscience Adrenergic Receptor CGP 20712 mesylate Inhibitor inhibitor inhibit